The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Open accessAbstract
BACKGROUND: Significant pain from HIV-associated sensory neuropathy (HIV-SN) affects ∼40% of HIV infected individuals treated with antiretroviral therapy (ART). The prevalence of HIV-SN has increased despite the more widespread use of ART. With the global HIV prevalence estimated at 33 million, and with infected individuals gaining increased access to ART, painful HIV-SN represents a large and expanding world health problem. There is an urgent need to develop effective pain management strategies for this condition. OBJECTIVE: To evaluate the clinical effectiveness of analgesics in treating painful HIV-SN. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Cochrane central register of controlled trials, www.clinicaltrials.gov, www.controlled-trials.com and the reference lists of retrieved articles. SELECTION CRITERIA: Prospective, double-blinded, randomised controlled trials (RCTs) investigating the pharmacological treatment of painful HIV-SN with sufficient quality assessed using a modified Jadad scoring method. REVIEW METHODS: Four authors assessed the eligibility of articles for inclusion. Agreement of inclusion was reached by consensus and arbitration. Two authors conducted data extraction and analysis. Dichotomous outcome measures (≥ 30% and ≥ 50% pain reduction) were sought from RCTs reporting interventions with statistically significant efficacies greater than placebo. These data were used to calculate RR and NNT values. RESULTS: Of 44 studies identified, 19 were RCTs. Of these, 14 fulfilled the inclusion criteria. Interventions demonstrating greater efficacy than placebo were smoked cannabis NNT 3.38 95%CI(1.38 to 4.10), topical capsaicin 8%, and recombinant human nerve growth factor (rhNGF). No superiority over placebo was reported in RCTs that examined amitriptyline (100mg/day), gabapentin (2.4 g/day), pregabalin (1200 mg/day), prosaptide (16 mg/day), peptide-T (6 mg/day), acetyl-L-carnitine (1g/day), mexilitine (600 mg/day), lamotrigine (600 mg/day) and topical capsaicin (0.075% q.d.s.). CONCLUSIONS: Evidence of efficacy exists only for capsaicin 8%, smoked cannabis and rhNGF. However,rhNGF is clinically unavailable and smoked cannabis cannot be recommended as routine therapy. Evaluation of novel management strategies for painful HIV-SN is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 3×
“This contrasts with the efficacy of these agents demonstrated in other peripheral neuropathic pain conditions [20] [59] [18,19].”
BackgroundResultStatistical Methods in Medical Research
Lachenbruch, P. A. (1972) · Technometrics · doi:10.1080/00401706.1972.10488903 · Cited by 1,703
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Antidepressants for neuropathic pain
Saarto, T., & Wiffen, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005454.pub2 · Cited by 764
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00003 · Cited by 748
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598 · cited 6×
“Abrams et al 2007 [40] Smoked cannabis: 3.”
BackgroundInfluentialYARCHOAN, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90283-8 · Cited by 512
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.120 · Cited by 461 · cited 5×
“Both of the RCTs that examined the efficacy of smoked cannabis, were of high quality, however the apparent marked superiority of smoked cannabis to placebo cigarettes should be tempered by the high proportion of potential unblinding measured in [41] (92% correctly guessing treatment allocation after treatment crossove…”
BackgroundInfluentialAnalgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review
Hempenstall, K., Nurmikko, T. J., Johnson, R. W., A'Hern, R. P., & Rice, A. S. C. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020164 · Cited by 400
Self-citationBaron, R., Tölle, T. R., Gockel, U., Brosz, M., & Freynhagen, R. (2009) · Pain · doi:10.1016/j.pain.2009.06.001 · Cited by 316
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
Simpson, D. M., Brown, S., & Tobias, J. (2008) · Neurology · doi:10.1212/01.wnl.0000314647.35825.9c · Cited by 308
Bacellar, H., Muñoz, A., Miller, E. N., Cohen, B. A., Besley, D., Seines, O. A., Becker, J. T., & McArthur, J. C. (1994) · Neurology · doi:10.1212/wnl.44.10.1892 · Cited by 307
Ellis, R. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.76 · Cited by 306
Shlay, J. C. (1998) · JAMA · doi:10.1001/jama.280.18.1590 · Cited by 305
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
McArthur, J. C., Yiannoutsos, C., Simpson, D. M., Adornato, B. T., Singer, E. J., Hollander, H., Marra, C., Rubin, M., Cohen, B. A., Tucker, T., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1080 · Cited by 286
A Novel Tool for the Assessment of Pain: Validation in Low Back Pain
Scholz, J., Mannion, R. J., Hord, D. E., Griffin, R. S., Rawal, B., Zheng, H., Scoffings, D., Phillips, A., Guo, J., Laing, R. J. C., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000047 · Cited by 262
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection
Kieburtz, K., Simpson, D., Yiannoutsos, C., Max, M. B., Hall, C. D., Ellis, R. J., Marra, C. M., McKendall, R., Singer, E., Dal Pan, G. J., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1682 · Cited by 246
A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
Simpson, D. M., Olney, R., McArthur, J. C., Khan, A., Godbold, J., Ebel-Frommer, K., & for the Lamotrigine HIV Neuropathy Study Group (2000) · Neurology · doi:10.1212/wnl.54.11.2115 · Cited by 242
Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial
Simpson, D. M., McArthur, J. C., Olney, R., Clifford, D., So, Y., Ross, D., Baird, B. J., Barrett, P., Hammer, A. E., & the Lamotrigine HIV Neuropathy Study Team (2003) · Neurology · doi:10.1212/01.wnl.0000063304.88470.d9 · Cited by 237
Cannabis use in HIV for pain and other medical symptoms
Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.07.011 · Cited by 208 · cited 1×
“The excluded articles included one clinical survey [42] and one review article [43].”
BackgroundPregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial
Simpson, D. M., Schifitto, G., Clifford, D. B., Murphy, T. K., Durso-De Cruz, E., Glue, P., Whalen, E., Emir, B., Scott, G. N., & Freeman, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ccc6ef · Cited by 198
Morgello, S. (2004) · Archives of Neurology · doi:10.1001/archneur.61.4.546 · Cited by 197
HIV neuropathy natural history cohort study: Assessment measures and risk factors
Simpson, D. M., Kitch, D., Evans, S. R., McArthur, J. C., Asmuth, D. M., Cohen, B., Goodkin, K., Gerschenson, M., So, Y., Marra, C. M., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000218303.48113.5d · Cited by 178
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies
Hahn, K., Arendt, G., Braun, J. S., Giesen, H.-J., Husstedt, I. W., Maschke, M., Straube, M. E., Schielke, E., & for the German Neuro-AIDS Working Group (2004) · Journal of Neurology · doi:10.1007/s00415-004-0529-6 · Cited by 177
Lamotrigine for acute and chronic pain
Wiffen, P. J., Derry, S., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006044.pub3 · Cited by 159
Lichtenstein, K. A., Armon, C., Baron, A. D., Moorman, A. C., Wood, K. C., Holmberg, S. D., & HIV Outpatient Study Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/426076 · Cited by 145
HIV neuropathy in South Africans: Frequency, characteristics, and risk factors
Maritz, J., Benatar, M. G., Dave, J. A., Harrison, T. B., Badri, M., Levitt, N. S., & Heckmann, J. M. (2010) · Muscle & Nerve · doi:10.1002/mus.21535 · Cited by 130
Topical Capsaicin in the Management of HIV-Associated Peripheral Neuropathy
Paice, J. A., Ferrans, C. E., Lashley, F. R., Shott, S., Vizgirda, V. M., & PITRAK, D. L. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00139-6 · Cited by 128
Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance
Tan, T., Barry, P., Reken, S., Baker, M., & On behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c1079 · Cited by 123
Prevalence of and risk factors for HIV‐associated neuropathy in Melbourne, Australia 1993–2006
Smyth, K., Affandi, J. S., McArthur, J. C., Bowtell-Harris, C., Mijch, A. M., Watson, K., Costello, K., Woolley, I. J., Price, P., Wesselingh, S. L., et al. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00478.x · Cited by 121
Self-citationDworkin, R. H., Katz, J., & Gitlin, M. J. (2005) · Neurology · doi:10.1212/wnl.65.12_suppl_4.s7 · Cited by 116
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy
Schifitto, G., Yiannoutsos, C. T., Simpson, D. M., Adornato, B. T., Singer, E. J., Hollander, H., Marra, C. M., Rubin, M., Cohen, B. A., Tucker, T., et al. (2001) · Neurology · doi:10.1212/wnl.57.7.1313 · Cited by 106
Herbal medicines for treating HIV infection and AIDS
Liu, J., Manheimer, E. W., & Yang, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003937.pub2 · Cited by 103
Silver, M. T., Blum, D., Grainger, J., Hammer, A. E., & Quessy, S. N. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.12.015 · Cited by 100
Hart, A. M., Wilson, A. D., Montovani, C., Smith, C. J., Johnson, M. A., Terenghi, G., & Youle, M. S. (2004) · AIDS · doi:10.1097/01.aids.0000131354.14408.fb · Cited by 96
Maratou, K., Wallace, V. C. J., Hasnie, F. S., Okuse, K., Hosseini, R., Jina, N., Blackbeard, J., Pheby, T., Orengo, C. A., Dickenson, A. H., et al. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.05.011 · Cited by 93
Self-citationYoule, M. S., Osio, M., & on behalf of the ALCAR Study Group (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00467.x · Cited by 89
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region
Wright, E., Brew, B. J., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., Lim, M. S. C., Vonthanak, S., Lal, L., Sarim, C., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000316390.17248.65 · Cited by 88
Self-citationA Randomized Controlled Trial of 5% Lidocaine Gel for HIV-Associated Distal Symmetric Polyneuropathy
Estanislao, L., Carter, K., McArthur, J. C., Olney, R. K., & Simpson, D. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200412150-00010 · Cited by 73
Lamotrigine for acute and chronic pain
Wiffen, P. J., & Rees, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006044.pub2 · Cited by 69
Acetyl-L-Carnitine in Neuropathic Pain: Experimental Data
Chiechio, S., Copani, A., Gereau, R. W., & Nicoletti, F. (2007) · CNS Drugs · doi:10.2165/00023210-200721001-00005 · Cited by 68
Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
Scarpini, E. A., Sacilotto, G., Baron, P., Cusini, M., & Scarlato, G. (1997) · PubMed · Cited by 67
Phillips, K. D., Skelton, W. D., & Hand, G. A. (2004) · The Journal of Alternative and Complementary Medicine · doi:10.1089/1075553041323678 · Cited by 66
Kemper, C. A., Kent, G., Burton, S., & Deresinski, S. C. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199812010-00007 · Cited by 62
Schifitto, G., Yiannoutsos, C. T., Simpson, D. M., Marra, C. M., Singer, E. J., Kolson, D. L., Nath, A., Berger, J. R., & NAVIA, B. A. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600873835 · Cited by 58
Osio, M., Muscia, F., Zampini, L., Nascimbene, C., Mailland, E., Cargnel, A., & Mariani, C. B. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00066.x · Cited by 56
Simpson, D. M., Dorfman, D., Olney, R. K., McKinley, G. F., Dobkin, J. F., So, Y. T., Berger, J. R., Ferdon, M. B., & Friedman, B. (1996) · Neurology · doi:10.1212/wnl.47.5.1254 · Cited by 56
Evans, S. R., Simpson, D. M., Kitch, D. W., King, A., Clifford, D. B., Cohen, B. A., & McArthur, J. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000551 · Cited by 43
Meta-Analysis in Clinical Research
Gelber, R. D., & Goldhirsch, A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-158_2 · Cited by 42
Reassessment of the role of cannabinoids in the management of pain
Beaulieu, P., & Ware, M. (2007) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282efd175 · Cited by 34
Long-Term Effect of Acetyl-L-Carnitine for Antiretroviral Toxic Neuropathy
Herzmann, C., Johnson, M. A., & Youle, M. S. (2005) · HIV Clinical Trials · doi:10.1310/ch1n-ybnu-g3cu-jbxr · Cited by 33
Lamotrigine for acute and chronic pain
Wiffen, P., McQuay, H., & Moore, R. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006044 · Cited by 28
Should cannabinoids be used as analgesics for neuropathic pain?
Rice, A. S. C. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0949 · Cited by 23
Self-citationFlecainide for the treatment of chronic neuropathic pain: a Phase II trial
von Gunten, C. F., Eappen, S., Cleary, J. F., Taylor, S. G., Moots, P. L., Regevik, N. K., Cleeland, C. S., & Cella, D. F. (2007) · Palliative Medicine · doi:10.1177/0269216307083031 · Cited by 17
(1999) · Complementary Therapies in Medicine · doi:10.1016/s0965-2299(99)80027-2 · Cited by 8
Cited by
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Self-citationTopical capsaicin (high concentration) for chronic neuropathic pain in adults
Derry, S., Rice, A. S., Cole, P., Tan, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub4 · Cited by 559
Self-citation
Metadata
- Authors
- Phillips, T. J. C., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-28
- Volume
- 5
- Issue
- 12
- Pages
- e14433
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1969554594
- Cited by
- 255
- References
- 63
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.